IPS PharmaAbout Miracle Alien Cookies (MAC)
MACHybridThe epic tale of Miracle Alien Cookies begins with the breeding of a Starfighter and a Columbian Gold landrace strain.
Bred by 
Capulator
As the story goes, Capulator tragically left the seeds in the pockets of a pair of pants that found their way into the washing machine. Attempting to revive the soapy seeds they were put into folded paper towels where they all germinated and seemed to be healthy. Unfortunately all but one of the seedlings had died. That sole survivor, the fifteenth to be planted and the only to survive, was thus dubbed “Miracle 15.” Miracle 15 was a male. This male was then bred with Alien Cookies introducing the world to an award winning strain to be known as Miracle Alien Cookies (M.A.C.).
Miracle Alien Cookies is a gorgeous resin-covered flower with a dank, gassy musk and sour citrus highlights. Our Phenotypes aroma and taste is unique with it's overwhelming garlicky gravy bite. Our Miracle Alien Cookies phenotype showcases what else the strain has to offer outside the infamous MAC1 cut.
Description provided by Durango Cannabis Co.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Somai Pharmaceuticals Inc.
Somaí, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specialising in cannabinoid-based medicines, is driving the global pharmaceutical cannabis market with a broad portfolio of EU-GMP-certified extracts.
Somaí is building a global brand focused on innovative cannabis-based therapeutics, with a vision of people living healthier lives supported by natural cannabis medicines.
The core strength of Somaí lies in its EU-GMP certification, which represents the gold standard for pharmaceutical manufacturing worldwide. This is particularly important in markets like the U.K., where there is a clear distinction between fully EU-GMP pharmaceutical products and less stringently regulated “Specials” or compounded extracts.
Somaí owns and operates its facilities under this highest standard:
- Somaí Pharmaceuticals – a state-of-the-art manufacturing facility in Lisbon, Portugal
- NovaSoma – an indoor cultivation facility, also in Lisbon, Portugal
Complete vertical integration—from indoor cultivation through to finished-dose manufacturing—under strict EU-GMP rules ensures batch-to-batch consistency, long-term stability data, and chemical reproducibility for patients. This level of quality and regulatory adherence allows Somaí's products to be supplied globally as true finished-dosage pharmaceutical extracts.
This commitment to the EU-GMP pharmaceutical standard enables Somaí to compete directly with established pharmaceutical manufacturers and to build one of the most advanced certified cannabinoid-containing extract portfolios worldwide.
somaipharma.eu
Further National Health-Service Information on